AABB

    AABB News Highlights COVID-19, Bleeding Disorders

    COVID-19 is having a significant impact on the blood community, and latest issue of AABB News contains several articles addressing the pandemic. The "High Priority" column summarizes actions by AABB and federal agencies in response to the coronavirus, including the $2 trillion Coronavirus Aid, Relief and Economic Security (CARES) Act; FDA's revised donor criteria; and updates to AABB's CCP protocol. In addition, the "Significant Findings" column describes new research on CCP from Shenzhen, China, and results from AABB's COVID-19 impact survey. The "Of Note" column contains items related to the pandemic, including summaries of Town Hall eCast lectures, which are complimentary and available on demand.

    Other articles include a feature on how existing technologies are being adapted for new at-risk populations; a feature on how CAR T-cell treatments offer patients with blood cancers an improved quality of life; and an interview with Stella Chou, MD, an associate professor of pediatrics at the University of Pennsylvania's Perelman School of Medicine and a pediatric hematologist and transfusion medicine specialist at the Children's Hospital of Philadelphia.

    Recent Stories
    AABB News Highlights COVID-19, Bleeding Disorders

    AABB Launches New COVID-19 Convalescent Plasma Website

    AABB Delays Effective Dates for BBTS, IRL Standards